Cisatracurium recalls

The FDA has published 5 recalls involving Cisatracurium since 2016. The latest was reported on 24 Dec 2025. Most were for foreign material. Somerset Therapeutics has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls5since 2016

Last 12 months3reported

Class I120% of total

Ongoing3latest 24 Dec 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 3 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 1 20%Class II 1 20%Class III 3 60%

Why cisatracurium is recalled

Foreign Material360%
Labeling Errors240%

Companies

Brands

Cisatracurium Besylate480%
Cisatracurium120%

By year

2025360%
2021120%
2016120%

Ongoing cisatracurium recalls

3 active

Reported	Class	Recall	Company	Reason	Where
24 Dec 2025Drug	CLASS III	Cisatracurium Besylate Injection USP, 10 mg/* (2mg/mL) recalledCisatracurium Besylate	Somerset Therapeutics	Foreign Material	Nationwide
24 Dec 2025Drug	CLASS III	Cisatracurium Besylate Injection USP, 200mg/*(10mg/mL) recalledCisatracurium Besylate	Somerset Therapeutics	Foreign Material	Nationwide
24 Dec 2025Drug	CLASS III	Cisatracurium Besylate Injection USP, 20 mg/*,(2 mg/mL) recalledCisatracurium Besylate	Somerset Therapeutics	Foreign Material	Nationwide

All cisatracurium recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
24 Dec 2025Drug	CLASS III	Cisatracurium Besylate Injection USP, 10 mg/* (2mg/mL) recalledCisatracurium Besylate	Somerset Therapeutics	Foreign Material	Nationwide
24 Dec 2025Drug	CLASS III	Cisatracurium Besylate Injection USP, 200mg/*(10mg/mL) recalledCisatracurium Besylate	Somerset Therapeutics	Foreign Material	Nationwide
24 Dec 2025Drug	CLASS III	Cisatracurium Besylate Injection USP, 20 mg/*,(2 mg/mL) recalledCisatracurium Besylate	Somerset Therapeutics	Foreign Material	Nationwide
3 Mar 2021Drug	CLASS I	Cisatracurium Besylate Injection, USP, 10mg recalledCisatracurium Besylate	Meitheal Pharmaceuticals	Labeling Errors	Nationwide
20 Apr 2016Drug	CLASS II	Cisatracurium Besylate Injection, 20 mg per (2 mg per mL) recalledCisatracurium	Fresenius Kabi USA	Labeling Errors	Nationwide

Should you stop taking Cisatracurium?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.